UF Health Cancer Center at Tandem meetings
The UF Health Cancer Center will be presenting at the 2023 Tandem Meetings Feb. 15-19.
The UF Health Cancer Center will be presenting at the 2023 Tandem Meetings Feb. 15-19.
The proposed guidance system uses electromagnetic tracking for an intuitive user interface and may improve prostate biopsy accuracy.
A team led by Dejana Braithwaite, Ph.D., created a tool to help older women and their primary care physicians make decisions on mammography screening.
The study will assess alpha/beta T-cell and B-cell depletion in allogeneic stem cell transplantation in malignant diseases.
In an interview with OncLive, Brian Ramnaraign, M.D., discusses the evaluation of atezolizumab plus tivozanib in a phase 1b/2 trial.
The gathering will provide information on prostate cancer prevention and new treatments, as well as offer opportunities to learn how to cope.
Carlos Rinaldi-Ramos, Ph.D., and Valérie de Crécy-Lagard, Ph.D., were elected AAAS fellows.
More than 400 local students attended the Cancer Research Symposium for High School Students on Jan. 26 in Ocala.
The UF College of Medicine's White Coat Company will perform on Feb. 14 for the UF Health Shands Children's Hospital.
The study will research detrimental mutations in the human SRP54 gene.